Home
>
National Drug Code (NDC)
>
STELARA
STELARA - 57894-060-03 - (ustekinumab)
Drug Information of STELARA
| Product NDC: | 57894-060 |
| Proprietary Name: | STELARA |
| Non Proprietary Name: | ustekinumab |
| Active Ingredient(s): | 45 mg/.5mL & nbsp; ustekinumab |
| Administration Route(s): | SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of STELARA
| Product NDC: | 57894-060 |
| Labeler Name: | Janssen Biotech, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125261 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20090925 |
Package Information of STELARA
| Package NDC: | 57894-060-03 |
| Package Description: | 1 SYRINGE in 1 CARTON (57894-060-03) > .5 mL in 1 SYRINGE |
NDC Information of STELARA
| NDC Code | 57894-060-03 |
| Proprietary Name | STELARA |
| Package Description | 1 SYRINGE in 1 CARTON (57894-060-03) > .5 mL in 1 SYRINGE |
| Product NDC | 57894-060 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ustekinumab |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | SUBCUTANEOUS |
| Start Marketing Date | 20090925 |
| Marketing Category Name | BLA |
| Labeler Name | Janssen Biotech, Inc. |
| Substance Name | USTEKINUMAB |
| Strength Number | 45 |
| Strength Unit | mg/.5mL |
| Pharmaceutical Classes |
